141 related articles for article (PubMed ID: 11929178)
1. Glucose and oxygen hypometabolism in aceruloplasminemia brains.
Miyajima H; Takahashi Y; Kono S; Sugimoto M; Suzuki Y; Hishida A; Sakamoto M; Ouchi Y
Intern Med; 2002 Mar; 41(3):186-90. PubMed ID: 11929178
[TBL] [Abstract][Full Text] [Related]
2. [Neuronal cell damage in aceruloplasminemia].
Miyajima H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):161-7. PubMed ID: 11215401
[TBL] [Abstract][Full Text] [Related]
3. Aceruloplasminemia, an inherited disorder of iron metabolism.
Miyajima H; Takahashi Y; Kono S
Biometals; 2003 Mar; 16(1):205-13. PubMed ID: 12572680
[TBL] [Abstract][Full Text] [Related]
4. Increased lipid peroxidation and mitochondrial dysfunction in aceruloplasminemia brains.
Miyajima H; Kono S; Takahashi Y; Sugimoto M
Blood Cells Mol Dis; 2002; 29(3):433-8. PubMed ID: 12547232
[TBL] [Abstract][Full Text] [Related]
5. Defective electron transfer in complexes I and IV in patients with aceruloplasminemia.
Kohno S; Miyajima H; Takahashi Y; Suzuki H; Hishida A
J Neurol Sci; 2000 Dec; 182(1):57-60. PubMed ID: 11102640
[TBL] [Abstract][Full Text] [Related]
6. Aceruloplasminemia.
Miyajima H
Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
[TBL] [Abstract][Full Text] [Related]
7. Aceruloplasminemia.
Kono S
Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
[TBL] [Abstract][Full Text] [Related]
8. Aceruloplasminemia, an iron metabolic disorder.
Miyajima H
Neuropathology; 2003 Dec; 23(4):345-50. PubMed ID: 14719552
[TBL] [Abstract][Full Text] [Related]
9. MR imaging for the quantitative assessment of brain iron in aceruloplasminemia: A postmortem validation study.
Vroegindeweij LHP; Wielopolski PA; Boon AJW; Wilson JHP; Verdijk RM; Zheng S; Bonnet S; Bossoni L; van der Weerd L; Hernandez-Tamames JA; Langendonk JG
Neuroimage; 2021 Dec; 245():118752. PubMed ID: 34823024
[TBL] [Abstract][Full Text] [Related]
10. Increased very long-chain fatty acids in erythrocyte membranes of patients with aceruloplasminemia.
Miyajima H; Adachi J; Tatsuno Y; Takahashi Y; Fujimoto M; Kaneko E; Gitlin JD
Neurology; 1998 Jan; 50(1):130-6. PubMed ID: 9443469
[TBL] [Abstract][Full Text] [Related]
11. Molecular and pathological basis of aceruloplasminemia.
Kono S; Miyajima H
Biol Res; 2006; 39(1):15-23. PubMed ID: 16629161
[TBL] [Abstract][Full Text] [Related]
12. Use of desferrioxamine in the treatment of aceruloplasminemia.
Miyajima H; Takahashi Y; Kamata T; Shimizu H; Sakai N; Gitlin JD
Ann Neurol; 1997 Mar; 41(3):404-7. PubMed ID: 9066364
[TBL] [Abstract][Full Text] [Related]
13. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
Zanardi A; Conti A; Cremonesi M; D'Adamo P; Gilberti E; Apostoli P; Cannistraci CV; Piperno A; David S; Alessio M
EMBO Mol Med; 2018 Jan; 10(1):91-106. PubMed ID: 29183916
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of Copper in the Iron-Rich Particles of Aceruloplasminemia Brain.
Yoshida K; Hayashi H; Wakusawa S; Shigemasa R; Koide R; Ishikawa T; Tatsumi Y; Kato K; Ohara S; Ikeda SI
Biol Trace Elem Res; 2017 Jan; 175(1):79-86. PubMed ID: 27272717
[TBL] [Abstract][Full Text] [Related]
15. Aceruloplasminemia: an update.
Kono S
Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
[TBL] [Abstract][Full Text] [Related]
16. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia.
Klomp LW; Gitlin JD
Hum Mol Genet; 1996 Dec; 5(12):1989-96. PubMed ID: 8968753
[TBL] [Abstract][Full Text] [Related]
17. Late onset diabetes mellitus in patients with hereditary aceruloplasminemia.
Miyajima H; Takahashi Y; Shimizu H; Sakai N; Kamata T; Kaneko E
Intern Med; 1996 Aug; 35(8):641-5. PubMed ID: 8894739
[TBL] [Abstract][Full Text] [Related]
18. Extensive brain pathology in a patient with aceruloplasminemia with a prolonged duration of illness.
Kaneko K; Hineno A; Yoshida K; Ohara S; Morita H; Ikeda S
Hum Pathol; 2012 Mar; 43(3):451-6. PubMed ID: 21889188
[TBL] [Abstract][Full Text] [Related]
19. Intracranial iron distribution and quantification in aceruloplasminemia: A case study.
Zhou L; Chen Y; Li Y; Gharabaghi S; Chen Y; Sethi SK; Wu Y; Haacke EM
Magn Reson Imaging; 2020 Jul; 70():29-35. PubMed ID: 32114188
[TBL] [Abstract][Full Text] [Related]
20. Brain and liver iron accumulation in aceruloplasminemia.
Fujita K; Osaki Y; Harada M; Kono S; Miyajima H; Izumi Y; Kaji R
Neurology; 2013 Dec; 81(24):2145-6. PubMed ID: 24323439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
